Skip to main content
Equibles

MORGAN STANLEY

Position in LENZ — LENZ Therapeutics, Inc.

CIK 895421 NEW YORK, NY
Back to LENZ Full portfolio

Position in LENZ

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,686,608
-$3,250,348 QoQ
Shares Held
472,995
-27.1% QoQ
Ownership
1.51%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in LENZ Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,661,229 across 524 Biotechnology names. LENZ ranks #194 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in LENZ

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,686,608 472,995
2026-03-31 $5,936,956 648,848
2025-12-31 $3,734,112 233,382
2025-09-30 $13,797,879 296,219
2025-06-30 $17,156,753 585,355
2025-03-31 $4,852,605 188,744
2024-12-31 $2,664,236 92,284
2024-09-30 $1,198,346 50,478
2024-06-30 $1,144,163 66,175
2024-03-31 $607,618 27,211